A systematic review of the economic evaluations of trastuzumab in metastatic breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A systematic review of the economic evaluations of trastuzumab in metastatic breast cancer

Published:2020-05-07 Issue:9 Volume:26 Page:1903-1905
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Petrou Panagiotis¹^ORCID

Affiliation:

1. Department of Life and Health Sciences, School of Sciences and Engineering, Pharmacy School Pharmacoepidemiology‐Pharmacovigilance University of Nicosia Nicosia Cyprus

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13853

Reference10 articles.

1. Use of the Monoclonal Antibody Anti-HER2 Trastuzumab in the Treatment of Metastatic Breast Cancer

2. Cost-Effectiveness Analysis of Trastuzumab (Herceptin) in HER2-Overexpressed Metastatic Breast Cancer

3. Cost-effectiveness of Herceptin®: A standard cost model for breast-cancer treatment in a Belgian university hospital

4. Cost‐effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2‐positive metastatic breast cancer in the United States;Diaby V;Breast Cancer Res Treat

5. A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model-based cost-effectiveness analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP